Investors Menu

Scott Tarriff

Scott Tarriff Biography

Scott Tarriff
Founder, President and Chief Executive Officer, Director

Scott Tarriff is the founder of Eagle Pharmaceuticals and has served as its Chief Executive Officer and as a member of the Board since its inception in January 2007. Mr. Tarriff has also served as Eagle’s President since September 2021. Prior to founding Eagle, Mr. Tarriff held several key executive-level positions at publicly traded companies. He joined Par Pharmaceutical Companies, Inc., a developer, manufacturer and marketer of specialty pharmaceuticals, in 1998 and served as President and Chief Executive Officer from September 2003 to September 2006 and on its Board of Directors from 2002 to 2006. Prior to that, Mr. Tarriff held various positions with Bristol-Myers Squibb, a biopharmaceutical company, including Senior Director-Marketing. Mr. Tarriff currently sits on the Board of Directors of Hackensack Meridian Health and Hackensack University Medical Center. He previously served on the Board of Directors of Clinical Data, Inc. and Synthetic Biologics, Inc., both publicly traded pharmaceutical companies.

In 2016, Mr. Tarriff received the prestigious Ernst and Young Entrepreneur Of The Year® Award in the Specialty Pharmaceutical category, New Jersey. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in areas such as innovation, financial performance, and personal commitment to their businesses and communities.

Mr. Tarriff holds a B.S. in marketing from Pennsylvania State University and an M.B.A. from Rider College.
 

    Change % Volume Data as of 10/15/2022 11:59 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

    Investor Contact

    In-Site
    Communications, Inc.
    Lisa M. Wilson,
    212-452-2793

    For all other media inquiries, please contact us.